PAK4 and prostate carcinoma: Notably, overexpression of PAK4 was detected in biopsies of tumor patients who lack immune cell infiltration and negative correlation between PAK4 expression and T cell infiltration has been evidenced in various tumors, such as pancreatic and prostate cancers featuring poor PD-1 blockade response (Abril-Rodriguez et al., 2020).